Skip Nav Destination
1-3 of 3
Sutapa Sinha, Pawan Kumar Vohra, Resham Bhattacharya, Shamit Dutta, Shirshendu Sinha, Debabrata Mukhopadhyay
J Cell Sci (2009) 122 (18): 3385–3392.
Published: 15 September 2009
... pathophysiological outcomes. Our previous studies have shown that the neurotransmitter dopamine could inhibit VEGF-induced phosphorylation of VEGF receptor 2 (VEGFR-2), endothelial cell proliferation, migration, microvascular permeability, and thus, angiogenesis. In this study, we address the mechanism by which...
Includes: Supplementary data
J Cell Sci (2005) 118 (15): 3523–3530.
Published: 01 August 2005
... dopamine synthesis by binding to and inhibiting tyrosine hydroxylase, the rate limiting enzyme in dopamine synthesis. Understanding α-synuclein function in dopaminergic cells should add to our knowledge of this key protein, which is implicated in Parkinson's disease and other disorders. Herein, we report...
J Cell Sci (2004) 117 (24): 5731–5737.
Published: 15 November 2004
...Gonçalo Castelo-Branco; Nina Rawal; Ernest Arenas Wnts are important regulators of dopamine (DA) neuron differentiation in the developing ventral mesencephalon and could thus serve as potential tools in the treatment of Parkinson's disease. In this study, we investigate whether established...